These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

640 related articles for article (PubMed ID: 23592772)

  • 1. Hyper-O-GlcNAcylation is anti-apoptotic and maintains constitutive NF-κB activity in pancreatic cancer cells.
    Ma Z; Vocadlo DJ; Vosseller K
    J Biol Chem; 2013 May; 288(21):15121-30. PubMed ID: 23592772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyper-
    Ma Z; Chalkley RJ; Vosseller K
    J Biol Chem; 2017 Jun; 292(22):9150-9163. PubMed ID: 28416608
    [No Abstract]   [Full Text] [Related]  

  • 3. OGT-mediated O-GlcNAcylation promotes NF-κB activation and inflammation in acute pancreatitis.
    Zhang D; Cai Y; Chen M; Gao L; Shen Y; Huang Z
    Inflamm Res; 2015 Dec; 64(12):943-52. PubMed ID: 26407569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical Role of Novel O-GlcNAcylation of S550 and S551 on the p65 Subunit of NF-κB in Pancreatic Cancer.
    Motolani A; Martin M; Wang B; Jiang G; Alipourgivi F; Huang X; Safa A; Liu Y; Lu T
    Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GFAT1/HBP/O-GlcNAcylation Axis Regulates
    Jia C; Li H; Fu D; Lan Y
    Biomed Res Int; 2020; 2020():1921609. PubMed ID: 32149084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional regulation of
    Qian K; Wang S; Fu M; Zhou J; Singh JP; Li MD; Yang Y; Zhang K; Wu J; Nie Y; Ruan HB; Yang X
    J Biol Chem; 2018 Sep; 293(36):13989-14000. PubMed ID: 30037904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased O-GlcNAcylation of NF-κB Enhances Retinal Ganglion Cell Death in Streptozotocin-induced Diabetic Retinopathy.
    Kim SJ; Yoo WS; Choi M; Chung I; Yoo JM; Choi WS
    Curr Eye Res; 2016; 41(2):249-57. PubMed ID: 25835259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RELA/NEAT1/miR-302a-3p/RELA feedback loop modulates pancreatic ductal adenocarcinoma cell proliferation and migration.
    Luo Z; Yi ZJ; Ou ZL; Han T; Wan T; Tang YC; Wang ZC; Huang FZ
    J Cell Physiol; 2019 Apr; 234(4):3583-3597. PubMed ID: 30362505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in O-Linked N-Acetylglucosamine (O-GlcNAc) Homeostasis Activate the p53 Pathway in Ovarian Cancer Cells.
    de Queiroz RM; Madan R; Chien J; Dias WB; Slawson C
    J Biol Chem; 2016 Sep; 291(36):18897-914. PubMed ID: 27402830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. O-GlcNAcylation of NF-κB Promotes Lung Metastasis of Cervical Cancer Cells via Upregulation of CXCR4 Expression.
    Ali A; Kim SH; Kim MJ; Choi MY; Kang SS; Cho GJ; Kim YS; Choi JY; Choi WS
    Mol Cells; 2017 Jul; 40(7):476-484. PubMed ID: 28681591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disruption of IkappaB kinase (IKK)-mediated RelA serine 536 phosphorylation sensitizes human multiple myeloma cells to histone deacetylase (HDAC) inhibitors.
    Dai Y; Chen S; Wang L; Pei XY; Funk VL; Kramer LB; Dent P; Grant S
    J Biol Chem; 2011 Sep; 286(39):34036-50. PubMed ID: 21816815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hexosamine biosynthetic pathway promotes the antiviral activity of SAMHD1 by enhancing O-GlcNAc transferase-mediated protein O-GlcNAcylation.
    Hu J; Gao Q; Yang Y; Xia J; Zhang W; Chen Y; Zhou Z; Chang L; Hu Y; Zhou H; Liang L; Li X; Long Q; Wang K; Huang A; Tang N
    Theranostics; 2021; 11(2):805-823. PubMed ID: 33391506
    [No Abstract]   [Full Text] [Related]  

  • 13. Chitosan oligosaccharides block LPS-induced O-GlcNAcylation of NF-κB and endothelial inflammatory response.
    Li Y; Liu H; Xu QS; Du YG; Xu J
    Carbohydr Polym; 2014 Jan; 99():568-78. PubMed ID: 24274545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. c-Rel is a critical mediator of NF-κB-dependent TRAIL resistance of pancreatic cancer cells.
    Geismann C; Grohmann F; Sebens S; Wirths G; Dreher A; Häsler R; Rosenstiel P; Hauser C; Egberts JH; Trauzold A; Schneider G; Sipos B; Zeissig S; Schreiber S; Schäfer H; Arlt A
    Cell Death Dis; 2014 Oct; 5(10):e1455. PubMed ID: 25299780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SOX9 activity is induced by oncogenic Kras to affect MDC1 and MCMs expression in pancreatic cancer.
    Zhou H; Qin Y; Ji S; Ling J; Fu J; Zhuang Z; Fan X; Song L; Yu X; Chiao PJ
    Oncogene; 2018 Feb; 37(7):912-923. PubMed ID: 29059173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single cell and bulk RNA expression analyses identify enhanced hexosamine biosynthetic pathway and O-GlcNAcylation in acute myeloid leukemia blasts and stem cells.
    Schauner R; Cress J; Hong C; Wald D; Ramakrishnan P
    Front Immunol; 2024; 15():1327405. PubMed ID: 38601153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogenic K-Ras and loss of Smad4 mediate invasion by activating an EGFR/NF-κB Axis that induces expression of MMP9 and uPA in human pancreas progenitor cells.
    Bera A; Zhao S; Cao L; Chiao PJ; Freeman JW
    PLoS One; 2013; 8(12):e82282. PubMed ID: 24340014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanistic insights of O-GlcNAcylation that promote progression of cholangiocarcinoma cells via nuclear translocation of NF-κB.
    Phoomak C; Vaeteewoottacharn K; Sawanyawisuth K; Seubwai W; Wongkham C; Silsirivanit A; Wongkham S
    Sci Rep; 2016 Jun; 6():27853. PubMed ID: 27290989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. mTOR/MYC Axis Regulates O-GlcNAc Transferase Expression and O-GlcNAcylation in Breast Cancer.
    Sodi VL; Khaku S; Krutilina R; Schwab LP; Vocadlo DJ; Seagroves TN; Reginato MJ
    Mol Cancer Res; 2015 May; 13(5):923-33. PubMed ID: 25636967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The therapeutic targeting of the FGFR1/Src/NF-κB signaling axis inhibits pancreatic ductal adenocarcinoma stemness and oncogenicity.
    Lai SW; Bamodu OA; Tsai WC; Chang YM; Lee WH; Yeh CT; Chao TY
    Clin Exp Metastasis; 2018 Oct; 35(7):663-677. PubMed ID: 29987671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.